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Abstract
Background: Over the last decade laparoscopic pancreatic surgery (LPS) has emerged as an alternative
to open pancreatic surgery (OPS) in selected patients with neuroendocrine tumours (NET) of the pancreas
(PNET). Evidence on the safety and efficacy of LPS is available from non-comparative studies.
Objectives: This study was designed as a meta-analysis of studies which allow a comparison of LPS
and OPS for resection of PNET.
Methods: Studies conducted from 1994 to 2012 and reporting on LPS and OPS were reviewed. Studies
considered were required to report on outcomes in more than 10 patients on at least one of the following:
operative time; hospital length of stay (LoS); intraoperative blood loss; postoperative morbidity; pancre-
atic fistula rates, and mortality. Outcomes were compared using weighted mean differences and odds
ratios.
Results: Eleven studies were included. These referred to 906 patients with PNET, of whom 22%
underwent LPS and 78% underwent OPS. Laparoscopic pancreatic surgery was associated with a lower
overall complication rate (38% in LPS versus 46% in OPS; P < 0.001). Blood loss and LoS were lower in
LPS by 67 ml (P < 0.001) and 5 days (P < 0.001), respectively. There were no differences in rates of
pancreatic fistula, operative time or mortality.
Conclusions: The nature of this meta-analysis is limited; nevertheless LPS for PNET appears to be safe
and is associated with a reduced complication rate and shorter LoS than OPS.
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Introduction
Minimally invasive pancreatic surgery was introduced in the early
1990s with a report on laparoscopic pylorus-preserving pancrea-
toduodenectomy by Gagner and Pomp1 and a report on pancre-
atic left resection by Cuschieri.2 Following this encouraging initial
experience, the technical feasibility of the procedure has been
demonstrated in case reports,3 in larger single-centre4 and multi-
institution5,6 cohorts, and in comparative studies.7–10 The laparo-
scopic approach to the resection of pancreatic lesions has been in
general considered with more caution than laparoscopic proce-
dures at other sites because of the inherent technical challenges of
pancreatic surgery and its propensity for perioperative complica-
tions. Three recent systematic reviews and meta-analyses con-
firmed that laparoscopic pancreatic surgery (LPS) is a safe
procedure.11–13 However, these reviews analysed results achieved in
distal pancreatectomy only and were not specific on the underly-
ing pathology. Whereas in several series adenocarcinomas have
dominated in the open pancreatic surgery (OPS) group, benign
lesions or tumours with low malignant potential have constituted
the majority of disease types in the LPS group. These inconsistent
entry criteria detract from the evidence on the efficacy of LPS in*These authors contributed equally to this paper.
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different pathologies encountered in pancreatic surgery. Pancre-
atic neuroendocrine tumours (PNET) present per se the ideal
entity for laparoscopic surgery because they are often small and of
less aggressive biological behaviour. A group associated with one
of the authors (LF-C) of the present review were among the first to
demonstrate that pancreatic resection performed using a laparo-
scopic approach in both apparently benign and malignant PNET
is a safe procedure providing longterm results comparable with
those achieved in open surgery.14
The purpose of this study is to evaluate the published literature
that allows for the comparison of LPS and OPS in the resection of
PNET. To the best of the present authors’ knowledge, this is the
first report to address such a comparison in the context of PNET.
The outcomes of each technique were quantified using the meta-
analytical method, while considering variations in the character-
istics of the various reports that might influence the overall
estimate of the outcome of interest.
Materials and methods
Study selection
A systematic review of the literature was performed using
MEDLINE/PubMed, EMBASE and the Cochrane Database of Sys-
tematic Reviews to identify all studies published until July 2012,
which reported data on outcomes of both LPS and OPS for PNET.
The systematic review protocol was registered to the PROS-
PERO registry and is available at: http://www.crd.york.ac.uk/
Prospero/display_record.asp?ID=CRD42011001727. The search
terms used were ‘neuroendocrine tumours’, ‘pancreatic surgery’,
‘pancreatic resection’, ‘conversion’, ‘blood loss’, ‘hospital stay’, ‘com-
plications’ and ‘mortality’ in various combinations.
The related articles function was used to extend the search.
References of the articles acquired were also searched manually.
All abstracts, studies and citations acquired were reviewed. The
last search was conducted on 15 July 2012.
Inclusion criteria
All published randomized and non-randomized studies, written
in English, French or German, allowing for the comparison of LPS
and OPS in the resection of PNET and including at least 10
patients in total were considered. To enter the analysis, studies
were required to refer to patients aged >18 years and to make an
objective evaluation of at least one of the outcome measures of
operative time, hospital length of stay (LoS), intraoperative blood
loss, postoperative morbidity, pancreatic fistula rate, and mortal-
ity. If more than one study was reported from the same institu-
tion, either the study with the larger sample size or the most recent
study was included, provided the outcome measures were not
mutually exclusive.
Exclusion criteria
Studies that failed to fulfil the inclusion criteria were excluded. In
addition, studies were excluded if they: (i) included children or
adolescents; (ii) included patients who did not undergo surgery;
(iii) did not report on the outcome measures already listed or did
not support the calculation of these outcome measures in their
published reports; (iv) focused on pathologies of pancreatic
lesions other than PNET; (v) included patients with PNET as a
subgroup, unless data were presented separately for each sub-
group, and (vi) included fewer than 10 patients in the PNET
subgroup.
Data extraction
Each study was independently assessed for eligibility by two
reviewers (PD and DAR) for inclusion or exclusion from the
review and data on the following were extracted: first author; year
of publication; country of origin; study design; characteristics of
the study population; number of subjects operated on with each
technique; rate of conversion from LPS to OPS, and perioperative
outcomes. Any differences were settled by consensus.
Outcomes of interest and definitions
Open and laparoscopic pancreatic surgery were compared on the
basis of several perioperative outcomes. These included overall
complication rate and postoperative fistula rate as primary out-
comes, and secondary outcomes such as operation duration,
intraoperative blood loss, hospital LoS and conversion to open
surgery. Patients in whom conversion had been performed were
retained in the LPS group as the meta-analysis was performed in
an intention-to-treat manner. Not all of the studies included had
defined the occurrence of pancreatic fistula according to the defi-
nition of the International Study Group on Pancreatic Fistula15
and therefore rates of pancreatic fistula were calculated on the
basis of the definitions used by the respective authors.
Statistical analysis
This study was performed in line with the recommendations of
the Cochrane Collaboration.16 Dichotomous variables were ana-
lysed using odds ratios (ORs), which represented the odds of an
event occurring in the LPS group compared with the OPS group.
An OR of < 1 favoured the LPS group and the point estimate for
the OR was considered statistically significant if the P-value was <
0.05, provided the 95% confidence interval (CI) did not include
the value 1. Studies that contained a zero value for an outcome of
interest in both the LPS and OPS arms were discarded from the
analysis for this particular event. If a study contained a zero value
for an event in one of the two groups, Yates’ correction was added.
The effect of Yates’ correction is to prevent the overestimation of
statistical significance for small data when ‘zero cells’ are present in
a 2 ¥ 2 contingency table. Such zero cells are reported to overes-
timate the OR measure and the corresponding standard deviation
(SD).17 For the Yates’ correction, a value of 0.5 is added to each
zero cell of the 2 ¥ 2 table for the study in question.
In the analysis of continuous variables the weighted mean dif-
ference (WMD) was calculated. A random-effect meta-analytical
technique was used for both continuous and dichotomous out-
comes. In a random-effect model, it is assumed that there is vari-
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ation among studies and therefore the calculated OR has a more
conservative value. The random-effect model was selected to
account for the heterogeneity produced by the inherent differ-
ences in the study population: patients were operated at different
centres by different surgeons; the selection criteria for each surgi-
cal technique were inconsistent, and patient risk profiles were
variable.
A qualitative assessment of the studies was performed, follow-
ing the Newcastle–Ottawa Scale.18 For the assessment, each study
was examined on three factors: patient selection; comparability of
the study groups, and assessment of the outcome. A score of 0–9
stars was assigned to each study according to the coding manual
for cohort studies of the Newcastle–Ottawa scale. Heterogeneity
was assessed in a sensitivity analysis using the following groups: (i)
all studies, and (ii) studies reporting only on insulinomas. A sen-
sitivity analysis on high- versus low-quality studies based on the
Newcastle–Ottawa score was not feasible as all included studies
scored between 6 (one study) and 7 (10 studies) on the relative
scale (Table 1).
Results
A total of 7172 potentially eligible published articles were identi-
fied in the literature search. The algorithm of the search is sum-
marized in Fig. 1. Eleven studies matched the selection criteria
and were suitable for meta-analysis.19–29 Studies included retro-
spective reviews (n = 10) and a prospective non-randomized trial
(NRCT) (n = 1). There were no randomized controlled trials
(RCTs) comparing the two procedures. A total of 906 patients
were included in the analysis, of whom 203 (22%) had LPS and
703 (78%) had OPS. A review of the data extraction showed there
to be agreement between the reviewers.
The characteristics of the studies are summarized in Table 1. All
studies included only PNET. In eight reports the underlying
pathology was an insulinoma. In the remaining three, both func-
tioning and non-functioning PNET were considered. Nine studies
reported conversion rates (range: 9–41%).
The results of the meta-analysis with regard to operative
parameters, postoperative complications, LoS and mortality will
be reported in detail. Other parameters considered in the data
extraction but for which data were not presented uniformly (such
as group characteristics, type of surgery performed, tumour size
and stage, readmission rates and transfusion rates) are presented
in Table 2.
Operative parameters
Eight studies reported on operative times20–22,24–27,29 (Fig. 2).
Mean operative times in both groups were almost identical (4 min
lower in the OPS group than the LPS group, 95% CI -19.2 to 26.9;
P = 0.740). Intraoperative blood loss was reported in seven
studies19–21,24,25,27,29 (Fig. 2). Blood loss was significantly lower in
the LPS group than in the OPS group by 67 ml (95% CI -116.3
to -17.4; P = 0.008).
Postoperative complications
Seven studies reported on the overall complication rate19–21,24,26–28
and nine studies19–22,24–27,29 reported on rates of observed pancre-
atic fistula (Fig. 3). Meta-analysis showed a significantly lower
incidence of overall morbidity of 36% (52 of 144) in LPS versus
46% (172 of 378) in OPS (OR = 0.52, 95% CI 0.30–0.89; P <
0.002). Pancreatic fistula rates did not differ between the two
groups [LPS: 51 events in 178 patients (29%); OPS: 146 events in
396 patients (37%); OR = 0.89, 95% CI 0.57–1.38; P = 0.590]. An
Table 1 Characteristics of studies reporting on patients with pancreatic neuroendocrine tumours (PNET) submitted to open pancreatic
surgery (OPS) or laparoscopic pancreatic surgery (LPS)














Espana-Gomez et al.19 2009 Retrospective Insulinomas 1995–2007 Spain 34 21 13 7 *******
Gumbs20 2008 Retrospective Functioning (23%)
Non-functioning (77%)
1992–2006 France 31 18 13 1 *******
Hu et al.21 2011 Retrospective Insulinomas 2000–2009 China 89 43 46 2 *******
Karaliotas & Sgourakis22 2009 Retrospective Insulinomas 1999–2008 Greece 12 5 7 1 *******
Kazanjian et al.23 2006 Retrospective Functioning (29%)
Non-functioning (71%)
1990–2005 USA 70 4 66 NR *******
Liu et al.24 2007 Retrospective Insulinomas 2000–2006 China 48 7 41 3 *******
Lo et al.25 2004 Retrospective Insulinomas 1999–2002 China 10 4 6 0 *******
Roland et al.26 2008 Retrospective Insulinomas 1998–2007 USA 37 22 15 2 *******
Sa Cunha et al.27 2006 Retrospective Insulinomas 1999–2005 China 21 12 9 3 ******
Zerbi et al.28 2011 Prospective Functioning (27%)
Non-functioning (73%)
2004–2007 Italy 262 21 241 NR *******
Zhao et al.29 2011 Retrospective Insulinomas 1990–2010 China 292 46 246 19 *******
Total 906 203 703
NR, not reported.
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overview of complications that were not reported uniformly
among the studies and for which a meta-analysis was not feasible
is presented in Table 3.
Length of hospital stay
Nine studies reported on the hospital LoS19–22,24–27,29 (Fig. 4). Meta-
analysis showed that LPS patients had a significantly lower LoS
compared with OPS patients amounting to a mean of 5 days (95%
CI -7.14 to -3.75; P < 0.00001).
Mortality
Only two studies19,28 reported data on postoperative mortality
(Fig. 5). These studies included totals of 42 patients in the LPS
group and 254 patients in the OPS group. Reported deaths num-
bered zero and three, respectively (OR 0.70, 95% CI 0.06–7.98;
P = 0.780).
Sensitivity analysis
The sensitivity analysis in this study included reports focusing
exclusively on insulinomas. Outcomes that could not be analysed
because of insufficient data (fewer than two studies reporting on
the outcome) were excluded from the sensitivity analysis. Sub-
group and sensitivity analyses on studies of high versus low
quality using the Newcastle–Ottawa scale were also attempted
(Table 1). This was not possible because all except one of the
Figure 1 Flow diagram of the literature search. PNET, pancreatic neuroendocrine tumour
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studies included scored 7 on the Newcastle–Ottawa scale. Further
assumptions considered for the sensitivity analysis included: (i)
tumour size; (ii) studies that matched treatment groups on clinical
and pathological data, particularly for functioning versus non-
functioning PNET, and (iii) studies that matched treatment
groups according to type of operation performed. However, data
could not be extracted for any of these groups and therefore
sensitivity analyses on these assumptions were not feasible.
Studies reporting on insulinomas
Eight studies19,21,22,24–27,29 reported exclusively on insulinomas. Dif-
ferences that remained statistically significant referred to hospital
LoS (P < 0.0001) and blood loss (P = 0.020). By contrast, overall
complication rates did not differ significantly between the OPS
and LPS groups (P = 0.120). Differences in operation duration
(P = 0.490) and pancreatic fistula rate (P = 0.780) were also
non-significant. Only one study reported mortality and therefore
mortality could not be assessed in this sensitivity subgroup analy-
sis. Data from the sensitivity analysis are presented in Table 4.
Discussion
This review confirms that laparoscopic resection is feasible and
safe in patients with PNET, in line with previous meta-analyses on
laparoscopic distal pancreas resection which analysed studies irre-
spective of the underlying pancreatic pathology reported.11–13
However, as in the previous meta-analyses on LPS versus OPS,
very few studies were found to have matched subjects in the study
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design or to have adjusted for confounders in the analysis. To
compensate for this problem, a sensitivity analysis for the studies
reporting on insulinomas was performed. Nevertheless, there is a
reporting bias that cannot be compensated for and this should be
considered in any interpretation of the results.
There has been growing acceptance of laparoscopic approaches
in pancreatic surgery in the last decade and an increasing number
of large case series and multi-institution studies have compared the
laparoscopic with the open approach in terms of safety and effi-
cacy.9,10,28,30 In a meta-analysis comparing laparoscopic with open
distal pancreas resection, Venkat et al.13 reported lower blood loss,
a lower overall rate of complications and a shorter hospital stay in
the laparoscopic arm. However, complications that may potentially
be associated with prolonged procedures (such as deep vein throm-
bosis) were not reported. There were no differences in rates of
pancreatic fistula, reoperation or mortality.13 There were no data
on the surgical techniques used, type of pancreatic stump closure
or use of drains.13 Moreover, in this meta-analysis,13 as in that
performed by Nigri et al.31 on the same subject with similar results,
outcomes were not correlated to specific underlying pancreatic
pathology. This is also true of most of the published series com-
paring laparoscopic with open pancreatic surgery, in which all
underlying pathologies are considered collectively for each
arm.9,10,32 Therefore, data attained from these studies must be inter-
preted with a caveat for the subgroup of PNET patients.9 Some of
the characteristics inherent to PNET are of special interest when
determining the optimal surgical approach. Patients with secreting
tumours are frequently diagnosed at an early stage of disease with
small tumours. Parenchyma-preserving limited pancreatic resec-
tion is the approach to pursue in this setting.33–36 In patients with
gastrinomas, a laparoscopic approach is generally not recom-
mended as 60–90% of patients will be found to have pancreatic
and/or submucosal duodenal lesions frequently associated with
lymph node metastases.37
Data for 906 patients, of whom 203 (22%) underwent LPS and
703 (78%) underwent OPS, were considered in this review. By
Figure 2 Meta-analysis of operative parameters: (a) length of operation [heterogeneity: t2 = 442.54; c2 = 14.78; d.f. = 7 (P = 0.04); I2 = 53%;
test for overall effect: Z = 0.33 (P = 0.74)], and (b) blood loss [heterogeneity: t2 = 2162.52; c2 = 15.96; d.f. = 6 (P = 0.01); I2 = 62%; test for
overall effect: Z = 2.65 (P = 0.008)]. SD, standard deviation; 95% CI, 95% confidence interval; squares, point estimates of treatment effects;
diamond, summary estimate from the pooled studies with 95% CIs
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contrast with data reported in single-centre series,10,38 both the
present report and other reviews comparing the laparoscopic and
open techniques13,31 show that overall morbidity is lower in LPS
patients than in OPS patients (36% and 45%, respectively). It is
noteworthy that no differences in pancreatic fistula rates emerged.
Nevertheless, these data should be interpreted with caution
because only a few studies defined complications according to
validated classification systems.15 The laparoscopic approach was
found to significantly reduce hospital LoS by 5 days and to lower
blood loss significantly by 67 ml (P < 0.008). Whether a difference
of 67 ml in intraoperative blood loss will have any impact on
clinical outcome remains a matter of debate. Only one study
reported on the actual blood units transfused in each group. Only
two studies reported on mortality and found no difference
between the groups. Several important issues in pancreatic
surgery for neuroendocrine tumours are functionality of the
tumour, type of tumour, tumour size and location, multi-
centricity, completeness of resection and regional lymph node
dissection.14,39 These were not properly addressed in most of the
studies.
An analysis of studies that allow for the comparison of different
procedures in a rare disease has several limitations. These limit the
nature of the meta-analysis itself. Firstly, some studies show dif-
ferences in sample sizes and the characteristics of each group that
are not always appropriately addressed. Secondly, because of the
inclusion of NRCTs, there is a selection bias in the treatment
groups. The pooling of data from NRCTs is a debated topic in the
field of meta-analysis. An NRCT may exaggerate the effect of an
intervention, either by intrinsic flaws or by external factors such as
publication bias. However, there is evidence that the pooling of
data from well-designed NRCTs of surgical procedures may be
reliable.40 Thirdly, there is heterogeneity produced by differences
Figure 3 Meta-analysis of postoperative complications: (a) overall complications [heterogeneity: t2 = 0.00; c2 = 5.92; d.f. = 6 (P = 0.43);
I2 = 0%; test for overall effect: Z = 2.40 (P = 0.02)], and (b) rates of pancreatic fistula [heterogeneity: t2 = 0.00; c2 = 6.65; d.f. = 8 (P = 0.57);
I2 = 0%; test for overall effect: Z = 0.54 (P = 0.59)]. 95% CI, 95% confidence interval; squares, point estimates of treatment effects;
diamond, summary estimate from the pooled studies with 95% CIs
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in definitions and measurements of the outcomes of interest that
may not have been reported in the study methodology. The
present study tried to address this issue by performing a quality
assessment and subgroup analysis. Fourthly, selective reporting
and non-publication bias introduce limitations that cannot be
accounted for. Finally, from a clinical point of view, it would be of
interest to compare LPS with OPS for further outcomes with
regard to tumour size, tumour histopathological classification and
types of operations performed in each group. Although the initial
aim of the present study was to extract relevant data and perform
such analyses, these data were either not reported at all or reported
only as descriptive statistics, thus making the pooling of data
impossible.
In conclusion, this meta-analysis shows that LPS is a safe
approach for PNETs. It is associated with a lower overall compli-
cation rate, less blood loss and a shorter hospital LoS compared
with the standard open technique. Operative times and rates of
pancreatic fistula are similar in LPS and OPS. There is no differ-














OPS LPS OPS LPS OPS LPS OPS LPS OPS LPS OPS LPS
Espana-Gomez et al.19 3 1 – – – – – – – – 4 5
Gumbs et al.20 2 3 1 – 1 – – 2 – 1 – 2
Hu et al.21 – – – – – – – 1 – – 5 3
Karaliotas & Sgourakis22 – – – – – – – – – – – –
Kazanjian et al.23 NR NR NR NR NR NR
Liu et al.24 – – – – 3 – – – – – 12 1
Lo et al.25 – – – – – – – – – – – –
Roland et al.26 1 0 – – – – – – – – 3 1
Sa Cunha et al.27 0 1 – – – – – – – – – –
Zerbi et al.28 NR NR NR NR NR NR
Zhao et al.29 16 1 – – – – 2 0 – – 3 0
Total 22 6 1 – 4 – 2 3 1 27 12
NR, not reported.
Figure 4 Meta-analysis of length of hospital stay [heterogeneity: t2 = 1.33; c2 = 10.15; d.f. = 8 (P = 0.25); I2 = 21%; test for overall effect:
Z = 6.29 (P < 0.0001)]. SD, standard deviation; 95% CI, 95% confidence interval; squares, point estimates of treatment effects; diamond,
summary estimate from the pooled studies with 95% CIs
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ence in mortality. This suggests that LPS is an option that should
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